Monitor for the actual SC 13D/A filing content to determine whether the activist investor increased or decreased their stake and whether their purpose or demands changed. The recent Q3 earnings (filed 3 days prior) showed strong revenue growth and first profitable quarter, which may influence activist strategy.
MDGL drugs
MDGL drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $432.79entry
- T+1 · 7d ago −0.04%α +0.32% · $432.60
- T+5 · 18h ago −2.04%α −0.35% · $423.96
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Analysis based on filing metadata only; document content was unavailable. This is an amendment to a Schedule 13D for Madrigal Pharmaceuticals, filed on November 6, 2026. Without the actual filing content, the activist's updated position, purpose, and intentions cannot be determined.
Key Facts
- Filing type: SC 13D/A (amended beneficial ownership report)
- Filed: November 6, 2026
- Company: Madrigal Pharmaceuticals (MDGL)
- Document content was unavailable for analysis
Financial Impact
Unknown, filing content unavailable
Risk Factors
- Filing content unavailable, analysis is based on metadata only
- Activist's updated position and intentions are unknown
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
18 reports on MDGL
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $424.08 Now $423.96 −0.03% settles Nov 23
- Nov 6, 202610d ago SC 13D/A Neutral 3/10 Viewing Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
- Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
- Nov 3, 202613d ago 8-K Bullish 7/10 No price data
- Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
- Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers